Management of specific underlying complications of Malaria
|
Manifestation/ complication
|
Management
|
Evaluation/investigation
|
|
Coma (cerebral malaria): impaired consciousness (or a Glasgow coma score < 11 in adults or a Blantyre coma score < 3 in children)
|
- Maintain airway; intubate, if necessary
- Place the patient on their side.
- Check for hypoglycemia and manage it if present.
- Give recommended empirical parental antibiotic for bacterial meningitis.
- Ensure proper nursing care to prevent aspiration and bed sores.
- Catheterize and record fluid input and urine output.
|
- Blood slide, random blood sugar, full blood count, serum urea/bicarbonate +/- LP
- Glasgow and Blantyre coma score monitoring
|
|
Convulsions (multiple convulsions): more than two episodes in 24 hr.
|
Maintain airway
In children:
- Treat promptly with diazepam (0.3 mg/ kg by IV or 0.5 mg/kg rectally), which can be repeated twice, and then shift to phenobarbitone
- Administer phenobarbitone (20 mg/kg IM loading dose over 20 min.) with respiratory support; if convulsions persist, give a maintenance dose of 5 mg/kg/day in two divided doses. Commence maintenance dose 24 hours after loading dose.
In adults:
- Give a slow bolus of IV diazepam 5–10 mg
- If convulsions continue, give a second dose.
- If they persist, give phenobarbitone 20 mg/ kg (IM or IV) over 20 min. as a loading dose (max. 100 mg); if convulsions persist, repeat phenobarbitone at 6 mg/kg after a 20-min. interval.
- For both children and adults, ensure the patient has received glucose and that body temperature is controlled
|
- Fit chart
- Urine for urinalysis to rule out eclampsia in pregnant women
|
|
Severe malarial anemia: hemoglobin concentration ≤5 g/dL or a hematocrit of ≤ 15% in children under 12 years old (< 7 g/dL and < 20%, respectively, in adults), with a parasite count > 10,000/μ
|
- Administer oxygen (2.5 L/mm) to improve oxygen delivery
- Prop up the patient with pillows or clothing
- Collect blood for cross match and hemoglobin estimations and transfuse, as appropriate
- Give packed cells at l0 ml/kg and whole blood at 20 ml/kg in cases of hypovolemic shock; give
- IV start (bolus) dose of a loop diuretic (e.g., furosemide) at 1–2 mg/kg (provided the blood pressure is not low) during blood transfusion to avoid circulatory overload
|
Monitoring for transfusion reactions
|
|
Pulmonary edema: radiologically confirmed or oxygen saturation < 92% on room air with a respiratory rate > 30/min, often with chest indrawing and crepitation’s on auscultation
|
- Prop up the patient and administer oxygen
- Give a diuretic (furosemide at 1 mg/kg IV bolus in children and 40 mg IV stat in adults)
- Stop IV fluids
- Intubate, where necessary
|
- Monitoring oxygen saturation, respiratory rate, and breathing difficulties
- Catheterization and monitoring of fluid input and urine output
- Chest x-ray
|
|
Acute kidney injury: urine output < 400 ml / 24 hr. (< 1 ml/kg in children) with a plasma or serum creatinine > 265 μmol/L (3 mg/dL) or blood urea > 20mmol/L
|
- Check for and correct dehydration
- Exclude heart failure
- Avoid herbal medication and nonsteroidal anti-inflammatory and nephrotoxic drugs (e.g., Gentamicin)
- Quickly refer patient to next level
|
- Blood draw for urea and creatinine
- Monitoring of fluid input and urine output
|
|
Hypoglycemia: blood glucose < 2.2 mmol/L or < 40 mg/dL
|
- Check blood glucose
- Correct hypoglycemia (≤ 3 mmol/L) with glucose (IV or oral); ensure adequate caloric intake (nutritional support) thereafter Immediately give 5 ml/kg of 10% dextrose through a peripheral line
- Continue with a slow IV infusion of 5 ml/kg/hr of 10% dextrose or 10 ml/kg/hr of 5% dextrose to prevent the recurrence of hypoglycemia
|
Monitoring of blood sugar levels and general condition
|
|
Shock: compensated (capillary refill ≥ 3 sec. or temperature gradient on leg [mid to proximal limb] but no hypotension) or decompensated (systolic blood pressure < 70 mm Hg in children or < 90 mm Hg in adults, with evidence of impaired perfusion [cool peripheries or prolonged capillary refill])
|
- Administer IV saline or Ringer’s lactate solution if serum lactate is normal
- Administer blood transfusion if the patient has associated anemia
- Give a third-generation cephalosporin or benzyl penicillin with Gentamicin to cover for bacteremia
|
- Monitoring of the central venous pressure while infusing the fluids, keeping it at 0–5 cm of H2O to avoid fluid overload
- Blood samples for culture
|
|
Spontaneous bleeding and coagulopathy
|
- Transfuse with screened fresh whole blood (cryoprecipitate, fresh frozen plasma, and platelets, if available)
- Give vitamin K injection (1 mg IM stat in children, 30 mg IM stat in adults)
|
Monitoring for bleeding and transfusion reactions
|
|
Metabolic acidosis: symptomology of rapid, deep, labored breathing with a base deficit of > 8 mEq/L or a plasma bicarbonate level of < 15 mmol/L or venous plasma lactate of ≥ 5 mmol/L or pH of < 7.35
|
- Exclude or treat hypoglycemia. Correct hypovolemia
- Treat septicemia with a third-generation cephalosporin
- If severe, consider hemofiltration or hemodialysis, or refer if these facilities are not available
|
- Close monitoring of vitals
- Blood samples for random blood sugar, culture, lactate, and bicarbonate
|
|
Hemoglobinuria: passing of dark, cola- colored urine
|
- Continue appropriate antimalarial treatment. Transfuse screened fresh blood, if necessary
- If oliguria develops and blood urea and serum creatinine levels rise (i.e., if acute renal injury occurs), consider renal replacement therapy
- If possible, refer the patient to a dialysis unit or center
|
- Monitoring of input and output
- Full blood count, urea, creatinine, and electrolytes
- Blood group match/save
|
Injectable artesunate is the drug of choice for the general population (children, adults, and pregnant women in all trimesters) with severe malaria. The recommended dosing schedule for artesunate is as follows:
- On admission (time = 0).
- After 12 hours.
- 24 hours after the initial dose.
- Once daily thereafter for a maximum of 6 days if the patient can still not tolerate oral medication.
The dosage is for artesunate is 3mg/kg for patient below 20kg and 2.4mg/kg for those 20kg and above.
After administering the initial parenteral treatment for a minimum of 24 hours, and once the patient regains consciousness and can take medications orally, discontinue parenteral therapy and commence the full course of an oral ACT. There should be an interval of at least 8 hours between the last dose of Artesunate and the first dose of an oral ACT.
Concomitant use of antibiotics
Septicemia and severe malaria may occur concurrently, particularly in children. Thus, broad-spectrum antibiotic treatment should be given with antimalarial drugs until bacterial infection is ruled out. Antibiotic treatment should be based on bacterial culture and sensitivity results or, if not available, follow local antibiotic sensitivity patterns
Referral Criteria
Complicated malaria should always be referred after initial management to a higher facility